Cancer Biology & Therapy

Peer-reviewed #oncology journal examining the molecular basis of cancer, with translational relevance to diagnosis and treatment. IF: 4.7
Views are our own.

[Cancer Biology & Therapy @CancerBiologyTx]

Volume 22 of Cancer Biology & Therapy is now online!

[Sidney Kimmel Comprehensive Cancer Center @KimmelCancerCtr]

In a currently open #ClinicalTrial, SKCC's Dr. Scott Waldman is determining the effectiveness of #linaclotide, a very small protein that binds to receptors on intestinal cells, in patients w/ #ColorectalCancer: https://t.co/XGRQVsyAZ3 #TrialTuesday #ColorectalCancerAwarenessMonth

[Cancer Biology & Therapy @CancerBiologyTx]

Great article defining the MOA of metformin as a #chemotherapy sensitizer. https://t.co/i9642T3rEC @hopkinskimmel #CancerResearch @Scott_Waldman EIC

[Cancer Biology & Therapy @CancerBiologyTx]

Salvage #sintilimab (PD1 inhibitor) following failed R-CHOP and CAR-T cell therapy for transformed follicular lymphoma https://t.co/7NM8abxNxO #lymphoma @UMGCCC #Immunotherapy @LillyPad @Scott_Waldman EIC

[Cancer Biology & Therapy @CancerBiologyTx]

Dead or alive? An issue in the voting booth as well as with the #TCGA datasets. https://t.co/IdGSG0Lbzv #CancerResearch #DataAnalytics #Genomics @Scott_Waldman EIC

[Cancer Biology & Therapy @CancerBiologyTx]

Another win for liquid biopsies. k-ras mutant detection for #PancreaticCancer after surgery @okayama_uni @rolfefoundation https://t.co/UXfn2n5CfP @Scott_Waldman EIC

[Cancer Biology & Therapy @CancerBiologyTx]

Progress in the fight against #pancreaticcancer. Great review https://t.co/vsBm9hg5df of the role of multi-D Tx for BRCA mutated metastatic pancreatic cancer @OHSUKnight @sloan_kettering @WeillCornell #Cancer @adamsnookphd @Scott_Waldman EIC

[Vivek Subbiah, MD @VivekSubbiah]

⭐️🚨Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency @NatureMedicine @OncoAlert #PrecisionMedicine
https://t.co/9qGjQzDnRQ

[Cancer Biology & Therapy @CancerBiologyTx]

Interested in the role of interleukin-2, ipilimumab, and anti-PD-1 in the management of metastatic #melanoma, check out the new review at https://t.co/iYBySy2Kr6 #immunotherapy #Cancer @hopkinskimmel @RushCancer @adamsnookphd @Scott_Waldman EIC

[Cancer Biology & Therapy @CancerBiologyTx]

Exciting data supporting combination of ONC201 (small molecule - imipridone class) and TRAIL for endometrial cancer https://t.co/iYBySxL9zy #cancer #cancerResearch #Immunotherapy

[Vivek Subbiah, MD @VivekSubbiah]

⭐️🔺Just in 👉🏼 LAG3 emerges as #Immunotherapy after PD1/PDL1 & CTLA4 👉🏼Relatlimab + Nivolumab versus Nivolumab in Untreated Advanced Melanoma ! @nejm @HTawbi_MD @MDAndersonNews https://t.co/yXo9UOlfcV

[Cancer Biology & Therapy @CancerBiologyTx]

Great review on the impact of oxygen and metabolic reprogramming on tumor cell metastases #cancer #CancerResearch @mvh_lab @LucasBSullivan @Scott_Waldman EIC

[Cancer Biology & Therapy @CancerBiologyTx]

Find out how NSUN6 regulates GBM response to TMZ independent of MGMT promoter status in the newly published article in @CancerBiologyTx by @chidiebereawah @WeillCornell #Cancer #cancerresearch @NIHBrainTumor @Scott_Waldman EIC

[Karen Knudsen, MBA PhD @DrKarenKnudsen]

ACS is proud to lead the national fight against #cancer. Millions of lives have been saved through funding research. In 2022, let's accelerate that effort! Learn more and join us in the fight at https://t.co/NrZRdJqS3E. @AmericanCancer
#oneACSagainstcancer

[Cancer Biology & Therapy @CancerBiologyTx]

Excellent review article on the role of the ubiquitin-proteasome and NFKB signal transduction pathway in skin cancer development https://t.co/YiaKh9CxGf #CancerTreatment #cancerresearch @skincancerorg @FoxChaseCancer

[Cancer Biology & Therapy @CancerBiologyTx]

@Scott_Waldman moving the needle forward on GUYC2C re-activation for colon cancer prevention https://t.co/x6RQ78ZttP For an excellent review @adamsnookphd on GUYC2C as a therapeutic target for GI cancers see https://t.co/ml1ohYsXRt #Gastroenterology #CANCER

[Nature Cancer @NatureCancer]

🍂🌰🥧 Our November issue @NatureCancer IS LIVE!

This month, read about RT and #Immunotherapy trials, #PancreaticCancer, macrophages & GBM therapy, SCC stemness, AML #metabolism and #therapy, #proteogenomics of lung cancer & much more!

DON'T MISS IT! 👇
https://t.co/ftei2oE3R6

[Cancer Biology & Therapy @CancerBiologyTx]

A systematic review of datasets that can help elucidate relationships among gene expression, race, and immunohistochemistry-defined subtypes in #breastcancer #PrecisionMedicine https://t.co/fUnFvpC7RI @breastcancer @BreastCancerNow

[Sarry Lab @jeansarry]

Intensively happy to share our newest study uncovering #mitochondrial adaptation as mechanism of response and #resistance to #BCL2 inhibitor combination in #AML #leukemia @NatureCancer.
Congratulations to our amazing PhD student Claudie Bosc and all co-authors.